Polo-like kinase in trypanosomes: an odd member out of the Polo family

被引:5
|
作者
Kurasawa, Yasuhiro [1 ]
An, Tai [1 ]
Li, Ziyin [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Trypanosoma brucei; Polo-like kinase; flagellum; cytokinesis; FLAGELLUM ATTACHMENT ZONE; CELL MORPHOGENESIS; BLOOD-STREAM; CYTOKINESIS INITIATION; CENTRIOLE DUPLICATION; LIFE-CYCLE; PROTEIN; BRUCEI; PLK1; PHOSPHORYLATION;
D O I
10.1098/rsob.200189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polo-like kinases (Plks) are evolutionarily conserved serine/threonine protein kinases playing crucial roles during multiple stages of mitosis and cytokinesis in yeast and animals. Plks are characterized by a unique Polo-box domain, which plays regulatory roles in controlling Plk activation, interacting with substrates and targeting Plk to specific subcellular locations. Plk activity and protein abundance are subject to temporal and spatial control through transcription, phosphorylation and proteolysis. In the early branching protists, Plk orthologues are present in some taxa, such as kinetoplastids and Giardia, but are lost in apicomplexans, such as Plasmodium. Works from characterizing a Plk orthologue in Trypanosoma brucei, a kinetoplastid protozoan, discover its essential roles in regulating the inheritance of flagellum-associated cytoskeleton and the initiation of cytokinesis, but not any stage of mitosis. These studies reveal evolutionarily conserved and species-specific features in the control of Plk activation, substrate recognition and protein abundance, and suggest the divergence of Plk function and regulation for specialized needs in this flagellated unicellular eukaryote.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Developing polo-like kinase 1 inhibitors
    Huang, Xufeng
    Xie, Zhouling
    Liao, Chenzhong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 869 - 871
  • [22] Human Polo-like Kinase Inhibitors as Antiplasmodials
    Bohmer, Monica J.
    Wang, Jinhua
    Istvan, Eva S.
    Luth, Madeline R.
    Collins, Jennifer E.
    Huttlin, Edward L.
    Wang, Lushun
    Mittal, Nimisha
    Hao, Mingfeng
    Kwiatkowski, Nicholas P.
    Gygi, Steven P.
    Chakrabarti, Ratna
    Deng, Xianming
    Goldberg, Daniel E.
    Winzeler, Elizabeth A.
    Gray, Nathanael S.
    Chakrabarti, Debopam
    ACS INFECTIOUS DISEASES, 2023, 9 (04): : 1004 - 1021
  • [23] Polo-like Kinase 4 Shapes Up
    Levine, Michelle S.
    Holland, Andrew J.
    STRUCTURE, 2014, 22 (08) : 1071 - 1073
  • [24] Polo-like kinase inhibitors in hematologic malignancies
    Talati, Chetasi
    Griffiths, Elizabeth A.
    Wetzler, Meir
    Wang, Eunice S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 200 - 210
  • [25] Regulation of cytokinesis by polo-like kinase 4
    Press, Michael F.
    Xie, Bin
    Davenport, Simon
    Zhou, Yu
    O'Brien, Neil
    Palazzolo, Michael
    Mak, Tak
    Brugge, Joan
    Slamon, Dennis J.
    CANCER RESEARCH, 2016, 76
  • [26] Polo-box domain interactions and kinase specificity of polo-like kinases
    Lowery, D
    Mohammad, D
    Yaffe, M
    FASEB JOURNAL, 2004, 18 (08): : C106 - C106
  • [27] Progress in the discovery of polo-like kinase inhibitors
    McInnes, C
    Mezna, M
    Fischer, PM
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 181 - 197
  • [28] Putting a bit into the polo-box domain of polo-like kinase 1
    Park J.-E.
    Kim T.-S.
    Meng L.
    Bang J.K.
    Kim B.Y.
    Lee K.S.
    Journal of Analytical Science and Technology, 6 (1)
  • [29] Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3
    Smith, Paul
    Syed, Nelofer
    Crook, Tim
    CELL CYCLE, 2006, 5 (12) : 1262 - 1264
  • [30] Polo-like kinases
    von Schubert, Conrad
    Nigg, Erich A.
    CURRENT BIOLOGY, 2013, 23 (06) : R225 - R227